Fundraising Fox

Newomics

Berkeley, US · Delaware corporation · 1 known investors

Find your way into Newomics

377 people in our graph share verified history with the Newomics team — schools, employers, funds. One of them is your warm intro.

Noubar Afeyanunlockedknows Pan Mao · together at Massachusetts Institute of Technology (overlapped)
×5knows the team · via Lawrence Berkeley National Laboratory
×5knows the team · via Massachusetts Institute of Technology
knows the team · via University of Science and Technology of China

Newomics develops the UniESI system, a multiomics front-end platform using its M3 emitter and MEA chip "multispray" technologies for microflow and nanoflow LC-MS. The system serves as a dual nano/micro ion source for mass spectrometers, targeting applications in native MS, proteomics, metabolomics, and single-cell omics.

BiotechDeep TechHardware

Founders & leadership

PMPan Mao
Pan MaoinCo-founderHe brings expertise in liquid chromatography, mass spectrometry, microfluidic chip design, and life science instrument development, with experience in product development, quality management systems, and cross-functional team leadership.
DWDaojing Wang
Daojing WanginCo-founder
PS
Patrick ScannonNamed on SEC filing

Board

THTed Hou
Ted HouinBoard directorManaging Partner at Berkeley Catalyst

Investors · 1

Berkeley CatalystBerkeley

Reported raises · per SEC filings

Form D private placements

$3.9M disclosed across 1 round · 2020

▶$3.9MraisedOct 2020 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Pan MaoDirector
  • Patrick ScannonDirector
  • Ted HouDirector
  • Daojing WangExecutive Officer, Director
Offering amount
$7.9M
Amount sold
$3.9M
First sale
Oct 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap
Sciex16 shared keywordsSCIEX develops mass spectrometry and capillary electrophoresis instruments, along with software and integrated workflows, for the precision detection and quantitation of molecules. Its products serve research scientists and clinical laboratories, including in vitro diagnostic applications.
Bruker10 shared keywordsBruker provides preclinical imaging solutions for research across oncology, neurology, cardiology, and other disease areas, serving academic institutions and pharmaceutical researchers.

Companies competing with Newomics for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 13 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2022$1.7M
National Institutes of Health (NIH)National Institutes of HealthPhase II2019$3M
National Institutes of Health (NIH)National Institutes of HealthPhase II2018$1.5M
National Institutes of Health (NIH)National Institutes of HealthPhase II2016$1.5M
National Institutes of Health (NIH)National Institutes of HealthPhase II2016$1.5M
National Institutes of Health (NIH)National Institutes of HealthPhase II2015$1.5M
National Institutes of Health (NIH)National Institutes of HealthPhase I2014$700K
National Institutes of Health (NIH)National Institutes of HealthPhase I2014$683.2K
National Institutes of Health (NIH)National Institutes of HealthPhase I2014$600K
National Institutes of Health (NIH)National Institutes of HealthPhase I2014$225K
National Institutes of Health (NIH)National Institutes of HealthPhase I2013$300K
National Institutes of Health (NIH)National Institutes of HealthPhase I2013$225K
National Institutes of Health (NIH)National Institutes of HealthPhase I2012$250K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Newomics do?
Newomics develops the UniESI system, a multiomics front-end platform using its M3 emitter and MEA chip "multispray" technologies for microflow and nanoflow LC-MS. The system serves as a dual nano/micro ion source for mass spectrometers, targeting applications in native MS, proteomics, metabolomics, and single-cell omics.
Who founded Newomics?
Newomics was founded by Pan Mao, Daojing Wang.
Who are Newomics's investors?
Newomics's investors include Berkeley Catalyst.
How much funding has Newomics raised?
Newomics has disclosed $3.9M raised across 1 round.
Where is Newomics headquartered?
Newomics is headquartered in Berkeley, US.